No abstract

Background: POLR1D is a subunit of RNA Polymerases I and III, which synthesize ribosomal RNAs. Dysregulation of these polymerases cause several types of diseases, including ribosomopathies. The craniofacial disorder Treacher Collins Syndrome (TCS) is a ribosomopathy caused by mutations in several subunits of RNA Polymerase I, including POLR1D. Here, we characterized the effect of a missense mutation in POLR1D and RNAi knockdown of POLR1D on Drosophila development. Results: We found that a missense mutation in Drosophila POLR1D (G30R) reduced larval rRNA levels, slowed larval growth, and arrested larval development. Remarkably, the G30R substitution is at an orthologous glycine in POLR1D that is mutated in a TCS patient (G52E). We showed that the G52E mutation in human POLR1D, and the comparable substitution (G30E) in Drosophila POLR1D, reduced their ability to heterodimerize with POLR1C in vitro. We also found that POLR1D is required early in the development of Drosophila neural cells. Furthermore, an RNAi screen revealed that POLR1D is also required for development of non-neural Drosophila cells, suggesting the possibility of defects in other cell types. Conclusions: These results establish a role for POLR1D in Drosophila development, and present Drosophila as an attractive model to evaluate the molecular defects of TCS mutations in POLR1D.

Treacher Collins Syndrome (TCS) is an extreme craniofacial disorder caused by mutations in genes important for RNA polymerase I (Pol I) transcription. Pol I is a multi‐subunit complex that transcribes ribosomal DNA (rDNA) to synthesize ribosomal RNA (rRNA). Two Pol I subunits often mutated in TCS are POLR1D and POLR1C which form a heterodimer that is important for Pol I complex assembly. Using fruit flies (D. melanogaster) as a model system, we mapped a fly POLR1D mutation that displays a severe developmental arrest phenotype in a clinically relevant residue where in a TCS patient this residue is mutated from a glycine residue to a bulky, negatively charged glutamic acid residue. In the fly mutant collection, this glycine residue is mutated to a bulkier but positively charged arginine residue. We used a simple in vitro co‐expression system to examine the biochemical impact of these mutations on fly and human POLR1D and POLR1C heterodimer formation in vitro. We also complement our in vitro work with a chimeric yeast (S. cerevisiae) model in vivo where together we found that in the same mutated residue, there is a defect that impacts heterodimer formation and Pol I and III complex integrity. Our results show that fly POLR1D is a suitable model system for human TCS mutants.

DNA‐dependent RNA Polymerases (Pols) are present in every living cell and even encoded by some viruses. Pols are responsible for the process of transcription, and Pols from the three domains of life are constructed of a conserved core complex that includes a dimer of α or α‐like subunits that serve as a scaffold for Pol assembly. Bacteria and archaea each encode a single Pol that transcribes all forms of RNA, while eukaryotes encode three specialized Pols (I‐III) containing one of two distinct α‐like heterodimers. One α‐like heterodimer is shared between Pols I and III, while there is a paralogous Pol II heterodimer. The α‐like subunits are clinically relevant as mutations in the Pol I/III heterodimer are associated with Treacher Collins Syndrome and 4H Leukodystrophy, while mutations in the Pol II heterodimer are associated with Primary Ovarian Insufficiency. These mutations often result in defects in Pol assembly and/or activity, although the vast majority remain uncharacterized. It is currently unclear if heterodimer formation is functionally similar in α‐like subunit orthologs and/or paralogs and how these similarities and differences can be used to study the α‐like subunit associated diseases. To examine this, we mutated several regions of the yeast and human small α‐like subunits to test their contribution to heterodimer interaction using several types of biochemical and genetic assays. Here we show that different regions serve differential roles in heterodimerization, in a polymerase‐ and species‐specific manner, with both human subunits being more sensitive to mutations. This suggests that although the subunits are evolutionary conserved, they interact differently. More broadly, these findings help explain why some disease mutations have little to no effect in yeast and possibly other model systems, and may inform us how to make better disease models in the future.